Targets for Alzheimer's disease: Lessons learnt from flies

M. Konsolaki; D. Cohen

doi:10.1016/S1741-8372(04)02395-3

Targets for Alzheimer's disease: Lessons learnt from flies

M. Konsolaki
, D. Cohen

Research output: Contribution to journal › Review article › peer-review

4 Scopus citations

Abstract

Neurodegenerative diseases, including Alzheimer's disease (AD), are a major focus of the pharmaceutical industry. Recently, human genetic analyses have aided in the successful identification of a handful of genes responsible for genetically inherited forms of AD, but our understanding of basic mechanisms that lead to the more common sporadic forms of this disease is still limited.

Original language	English (US)
Pages (from-to)	64-70
Number of pages	7
Journal	Drug Discovery Today: TARGETS
Volume	3
Issue number	2
DOIs	https://doi.org/10.1016/S1741-8372(04)02395-3
State	Published - Apr 2004
Externally published	Yes

All Science Journal Classification (ASJC) codes

Drug Discovery

Keywords

Alzheimer's Disease
Drosophila
Drug Discovery
Genetics
Molecular Medicine
Neurobiology
Pharmaceutical Science
beta-amyloid
disease pathways
genetic analysis

Access to Document

10.1016/S1741-8372(04)02395-3

Cite this

@article{454e9ed45115440b874ab5cc61f13327,

title = "Targets for Alzheimer's disease: Lessons learnt from flies",

abstract = "Neurodegenerative diseases, including Alzheimer's disease (AD), are a major focus of the pharmaceutical industry. Recently, human genetic analyses have aided in the successful identification of a handful of genes responsible for genetically inherited forms of AD, but our understanding of basic mechanisms that lead to the more common sporadic forms of this disease is still limited.",

keywords = "Alzheimer's Disease, Drosophila, Drug Discovery, Genetics, Molecular Medicine, Neurobiology, Pharmaceutical Science, beta-amyloid, disease pathways, genetic analysis",

author = "M. Konsolaki and D. Cohen",

year = "2004",

month = apr,

doi = "10.1016/S1741-8372(04)02395-3",

language = "English (US)",

volume = "3",

pages = "64--70",

journal = "Drug Discovery Today: TARGETS",

issn = "1741-8372",

publisher = "Elsevier B.V.",

number = "2",

}

TY - JOUR

T1 - Targets for Alzheimer's disease

T2 - Lessons learnt from flies

AU - Konsolaki, M.

AU - Cohen, D.

PY - 2004/4

Y1 - 2004/4

N2 - Neurodegenerative diseases, including Alzheimer's disease (AD), are a major focus of the pharmaceutical industry. Recently, human genetic analyses have aided in the successful identification of a handful of genes responsible for genetically inherited forms of AD, but our understanding of basic mechanisms that lead to the more common sporadic forms of this disease is still limited.

AB - Neurodegenerative diseases, including Alzheimer's disease (AD), are a major focus of the pharmaceutical industry. Recently, human genetic analyses have aided in the successful identification of a handful of genes responsible for genetically inherited forms of AD, but our understanding of basic mechanisms that lead to the more common sporadic forms of this disease is still limited.

KW - Alzheimer's Disease

KW - Drosophila

KW - Drug Discovery

KW - Genetics

KW - Molecular Medicine

KW - Neurobiology

KW - Pharmaceutical Science

KW - beta-amyloid

KW - disease pathways

KW - genetic analysis

UR - https://www.scopus.com/pages/publications/8844226196

UR - https://www.scopus.com/pages/publications/8844226196#tab=citedBy

U2 - 10.1016/S1741-8372(04)02395-3

DO - 10.1016/S1741-8372(04)02395-3

M3 - Review article

AN - SCOPUS:8844226196

SN - 1741-8372

VL - 3

SP - 64

EP - 70

JO - Drug Discovery Today: TARGETS

JF - Drug Discovery Today: TARGETS

IS - 2

ER -

Targets for Alzheimer's disease: Lessons learnt from flies

Abstract

All Science Journal Classification (ASJC) codes

Keywords

Access to Document

Other files and links

Fingerprint

Cite this